Middle East Healthcare Company SJSC
SAU:4009
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
68
131.4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SAR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Middle East Healthcare Company SJSC
Middle East Healthcare Company SJSC
Total Receivables
Middle East Healthcare Company SJSC
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Middle East Healthcare Company SJSC
SAU:4009
|
Total Receivables
ď·Ľ2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Dallah Healthcare Company SJSC
SAU:4004
|
Total Receivables
ď·Ľ828.8m
|
CAGR 3-Years
7%
|
CAGR 5-Years
18%
|
CAGR 10-Years
13%
|
|
|
National Medical Care Company JSC
SAU:4005
|
Total Receivables
ď·Ľ763m
|
CAGR 3-Years
8%
|
CAGR 5-Years
10%
|
CAGR 10-Years
7%
|
|
|
Mouwasat Medical Services Company SJSC
SAU:4002
|
Total Receivables
ď·Ľ1.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
11%
|
CAGR 10-Years
17%
|
|
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
Total Receivables
ď·Ľ769.5m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
D
|
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017
|
Total Receivables
ď·Ľ895.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Middle East Healthcare Company SJSC
Glance View
Middle East Healthcare Company SJSC, better known as Saudi German Health, has intricately woven itself into the fabric of healthcare across the Kingdom of Saudi Arabia and the Middle East. Founded as a formidable player in the healthcare sector, it operates a network of hospitals offering a wide spectrum of medical services. This renowned healthcare provider draws its strength from combining advanced technology and erudite medical expertise. Through its comprehensive facilities, it provides specialized healthcare services, ranging from general medicine and surgery to complex specializations such as pediatrics, orthopedics, oncology, and cardiovascular services. By ensuring access to quality medical services, the company doesn't just treat ailments but also fosters health education and preventive care initiatives, reflecting a holistic approach to healthcare. The business model of Saudi German Health is anchored upon its impressive ability to harness a steady stream of revenue from its multi-faceted services. The company epitomizes a dual approach: revenue is generated through patient care across different hospitals while concurrently they leverage economies of scale. It's not just about treating people; the company strategically invests in state-of-the-art diagnostic and emergency response facilities, which serve to attract a vast patient base. By continuously expanding its network and employing a team of highly qualified medical professionals, Middle East Healthcare Company SJSC positions itself as a leader in the evolving landscape of healthcare in the region. Their consistent focus on enhancing healthcare delivery positions them for sustained growth in an industry that thrives on people’s well-being.
See Also
What is Middle East Healthcare Company SJSC's Total Receivables?
Total Receivables
2B
SAR
Based on the financial report for Sep 30, 2024, Middle East Healthcare Company SJSC's Total Receivables amounts to 2B SAR.
What is Middle East Healthcare Company SJSC's Total Receivables growth rate?
Total Receivables CAGR 5Y
13%
Over the last year, the Total Receivables growth was 22%. The average annual Total Receivables growth rates for Middle East Healthcare Company SJSC have been 11% over the past three years , 13% over the past five years .
You don't have any saved screeners yet